Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
101
Number of overlapping holdings
100.0%
% of IYH's 104 holdings also in FHLC
31.4%
% of FHLC's 349 holdings also in IYH
Overlap by Weight
Sector Drift (IYH minus FHLC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 11.3% | 11.3% |
|
UNITEDHEALTH GROUP INC | 8.3% | 7.3% | 7.3% |
|
JOHNSON & JOHNSON | 7.5% | 6.4% | 6.4% |
|
ABBVIE INC | 6.1% | 6.1% | 6.1% |
|
MERCK & CO. INC. | 3.9% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
IYH Overweight Relative to FHLC
|
ELI LILLY & CO | 2.1% |
|
JOHNSON & JOHNSON | 1.1% |
|
UNITEDHEALTH GROUP INC | 1.0% |
|
ABBOTT LABORATORIES | 0.7% |
|
VERTEX PHARMACEUTICALS INC | 0.5% |
|
ELEVANCE HEALTH INC | 0.4% |
|
BOSTON SCIENTIFIC CORP | 0.4% |
|
INTUITIVE SURGICAL INC | 0.4% |
|
STRYKER CORP | 0.4% |
|
CIGNA CORPORATION | 0.3% |
IYH Underweight Relative to FHLC
|
CVS CAREMARK CORP | -1.3% |
|
MCKESSON CORP | -1.3% |
|
CENCORA INC | -0.7% |
 |
METTLER-TOLEDO INTERNATIONAL | -0.4% |
|
INTRA-CELLULAR THERAPIES INC | -0.2% |
|
INSMED INC | -0.2% |
|
HEALTHEQUITY INC | -0.1% |
|
VAXCYTE, INC. | -0.1% |
|
LANTHEUS HOLDINGS INC | -0.1% |
|
HALOZYME THERAPEUTICS INC | -0.1% |